BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A prospective, single-arm, longitudinal study

Am J Hematol. 2022 Apr;97(4):E141-E144. doi: 10.1002/ajh.26462. Epub 2022 Jan 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Longitudinal Studies
  • Prospective Studies
  • RNA, Messenger
  • SARS-CoV-2
  • Thrombophilia* / etiology
  • Up-Regulation
  • Vaccination

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine